2021
DOI: 10.1055/s-0041-1725164
|View full text |Cite
|
Sign up to set email alerts
|

Non-Hyaluronic Acid Fillers for Midface Augmentation: A Systematic Review

Abstract: There has been an increasing role in the use of injectable fillers for rejuvenation of the aging face. In this systematic review, we aim to evaluate the existing literature related to soft tissue fillers of the midface. Specifically, we focus on the non-hyaluronic acid fillers including polymethylmethacrylate (PMMA), poly-L-lactic acid (PLLA), calcium hydroxyapatite (CaHA), and autologous fat. A systematic review was conducted in November 2020 in accordance with Preferred Reporting Items for Systematic Reviews… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(16 citation statements)
references
References 34 publications
0
12
0
Order By: Relevance
“…However, some studies have found that the monomer of polyacrylamide hydrogel is neurotoxic and the incidence of adverse reactions such as pain, deformity, and persistent swelling is high, 8 Food and Drug Administration in China has banned the use of Olmaxidine for medical treatment for more than 10 years; however, there are still a large number of people who are carriers of Olmeidine which exists potential risk. The main components of calcium hydroxyapatite‐based filler are mainly extracted from bones and teeth; therefore, it has high histocompatibility and is non‐toxic 9 . Calcium hydroxyapatite‐based filler is often used to fill moderate or severe facial wrinkles, 10 which is not easily displaced, and can stimulate fibroblast proliferation and collagen formation, improve skin quality, and the effect is stable and lasting.…”
Section: Discussionmentioning
confidence: 99%
“…However, some studies have found that the monomer of polyacrylamide hydrogel is neurotoxic and the incidence of adverse reactions such as pain, deformity, and persistent swelling is high, 8 Food and Drug Administration in China has banned the use of Olmaxidine for medical treatment for more than 10 years; however, there are still a large number of people who are carriers of Olmeidine which exists potential risk. The main components of calcium hydroxyapatite‐based filler are mainly extracted from bones and teeth; therefore, it has high histocompatibility and is non‐toxic 9 . Calcium hydroxyapatite‐based filler is often used to fill moderate or severe facial wrinkles, 10 which is not easily displaced, and can stimulate fibroblast proliferation and collagen formation, improve skin quality, and the effect is stable and lasting.…”
Section: Discussionmentioning
confidence: 99%
“…There are limitations to this study. We solely focused on HA-based IDFs and other types of soft tissue fillers based on different materials (e.g., polymethylmethacrylate, poly-L-lactic acid, and calcium hydroxyapatite) [22] were not included in our comparative analysis. Additionally, four biomarkers measured in our research (i.e., type I collagen, III collagen, elastin, and TGF-β1) were selected based on the existing knowledge about fibroblast response to IDFs; the remaining two markers (i.e., IL-1β and 8-OHdG) were included as indicators of inflammation and oxidative DNA damage, respectively.…”
Section: Discussionmentioning
confidence: 99%
“…The AFIL is safe and with good efficacy for UVPF. The materials that had a longer duration with permanent (long-lasting) effects in the body include autologous fat, calcium hydroxylapatite (Radiesse), ArteSense, and particulate silicone [ 31 ]. Autologous fat is safe and widely accepted with fewer adverse effects such as umbilical herniation [ 32 ].…”
Section: Discussionmentioning
confidence: 99%